Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Europe
Europe
Biogen’s Best-Selling Drug Loses Patent In EU, Says Cowen
Investors.com
Fri, 03/11/16 - 09:37 am
Biogen
patents
Europe
Tecfidera
MS
multiple sclerosis
Teva's $40.5B deal for Allergan generics arm reportedly close to EU approval
BioPharma Dive
Thu, 03/10/16 - 10:53 am
Teva Pharmaceutical
Allergan
generics
M&A
Europe
Sanofi and Merck pull the plug on European vaccines venture
Yahoo/Reuters
Tue, 03/8/16 - 10:19 am
Sanofi
Merck
Europe
vaccines
Europe takes a page from the FDA with new speedy approval program
Fierce Biotech
Tue, 03/8/16 - 10:17 am
Europe
FDA
drug approvals
R&D
Gilead Sciences Moves a Step Ahead in HBV Market Gilead Sciences Moves a Step Ahead in HBV Market
Bidness, ETC
Fri, 02/26/16 - 10:28 pm
Gilead Sciences
hepatitis B
Europe
Gilead's HIV drug gets closer to getting Europe approval
Yahoo/Reuters
Fri, 02/26/16 - 10:19 am
Gilead Sciences
HIV
Europe
Descovy
Lilly's lung cancer drug Portrazza wins EU approval as first-line biologic
BioPharma Dive
Fri, 02/26/16 - 09:34 am
Eli Lilly
Portrazza
Europe
biologics
non-small cell lung cancer
AstraZeneca bags EU approval for gout drug Zurampic as it eyes $500M in sales
Fierce Pharma
Sat, 02/20/16 - 09:16 am
AstraZeneca
Europe
gout
Zurampic
Brilique
Teva to hawk $1 billion in assets to clear massive Allergan generics deal
BioPharma Dive
Fri, 02/19/16 - 11:11 am
Teva
Europe
Allergan
generics
M&A
Teva Makes Concessions in EU Review of Bid for Allergan Unit
Bloomberg
Fri, 02/19/16 - 10:10 am
Teva Pharmaceutical
Allergan
Europe
M&A
Teva Said to Seek Fast EU Approval for Allergan Unit Bid
Bloomberg
Thu, 02/18/16 - 09:34 am
Teva Pharmaceutical
M&A
Allergan
Europe
generics
U.S., EU medical device associations push ‘regulatory cooperation’
Mass Device
Sat, 02/13/16 - 09:23 am
Europe
United States
devices
regulatory
Heptares plans Alzheimer's PhII; AstraZeneca ends I-O trial rollout; 4D buys microbiome firm
Fierce Biotech
Fri, 02/12/16 - 09:51 am
AstraZeneca
Heptares Therapeutics
Europe
EU agency accepts Sandoz application for pegfilgrastim biosimilar
Yahoo/Reuters
Thu, 02/11/16 - 09:16 am
Europe
Sandoz
Novartis
biosimilars
pegfilgrastim
Neulasta
AstraZeneca's potential lung cancer blockbuster nabs EU approval
BioPharma Dive
Thu, 02/4/16 - 06:25 pm
AstraZeneca
lung cancer
Europe
Tagrisso
Merck, Sanofi Exploring Potential End To Joint Venture In Europe
Yahoo/Benzinga
Wed, 02/3/16 - 08:26 am
Merck
Sanofi
Europe
vaccines
Amgen Loses Enbrel to Biogen in Europe; Can It Cope?
Bidness, ETC
Tue, 01/19/16 - 10:39 am
Amgen
Biogen
Europe
Enbrel
Samsung Bioepis
biosimilars
Amgen wins quick EU approval for Imlygic, its first-in-class immuno-oncology drug
Fierce Pharma
Sun, 12/20/15 - 04:32 pm
Amgen
Europe
Imlygic
melanoma
EMA chief: Faster drug approvals can quell Rx sticker shock
BioPharma Dive
Thu, 12/10/15 - 11:08 am
Europe
drug approvals
EMA
For Hepatitis C Drugs, U.S. Prices Are Cheaper Than In Europe
Forbes
Fri, 12/4/15 - 08:13 pm
hepatitis C
Europe
drug pricing
Pages
« first
‹ previous
…
28
29
30
31
32
33
34
35
36
…
next ›
last »